Reducing antibody levels in patients undergoing transplantation

被引:14
作者
Shapiro, Ron [1 ]
机构
[1] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA
关键词
D O I
10.1056/NEJMe0804275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:305 / 306
页数:2
相关论文
共 11 条
[2]   Kidney and pancreas transplantation in the United States, 1996-2005 [J].
Andreoni, K. A. ;
Brayman, K. L. ;
Guidinger, M. K. ;
Sommers, C. M. ;
Sung, R. S. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (05) :1359-1375
[3]   Overcoming a positive crossmatch in living-donor kidney transplantation [J].
Gloor, JM ;
DeGoey, SR ;
Pineda, AA ;
Moore, SB ;
Prieto, M ;
Nyberg, SL ;
Larson, TS ;
Griffin, MD ;
Textor, SC ;
Velosa, JA ;
Schwab, TR ;
Fix, LA ;
Stegall, MD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (08) :1017-1023
[4]   Evaluation of intravenous immunoglobulin as are agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIHIG02 trial [J].
Jordan, SC ;
Tyan, D ;
Stablein, D ;
Mcintosh, M ;
Rose, S ;
Vo, A ;
Toyoda, M ;
Davis, C ;
Shapiro, R ;
Adey, D ;
Milliner, D ;
Graff, R ;
Steiner, R ;
Ciancio, G ;
Sahney, S ;
Light, J .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (12) :3256-3262
[5]   Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients [J].
Montgomery, RA ;
Zachary, AA ;
Racusen, LC ;
Leffell, MS ;
King, KE ;
Burdick, J ;
Maley, WR ;
Ratner, LE .
TRANSPLANTATION, 2000, 70 (06) :887-895
[6]  
*ORG PROC TRANSPL, SCI REG TRANSPL REC
[7]  
PALMER A, 1987, TRANSPLANT P, V19, P3750
[8]   COMPARISON OF SURVIVAL PROBABILITIES FOR DIALYSIS PATIENTS VS CADAVERIC RENAL-TRANSPLANT RECIPIENTS [J].
PORT, FK ;
WOLFE, RA ;
MAUGER, EA ;
BERLING, DP ;
JIANG, KH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (11) :1339-1343
[9]   COMPARISON OF QUALITY OF LIFE OF PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, HEMODIALYSIS, AND AFTER TRANSPLANTATION [J].
SIMMONS, RG ;
ANDERSON, C ;
KAMSTRA, L .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1984, 4 (03) :253-255
[10]   Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics [J].
Vieira, CA ;
Agarwal, A ;
Book, BK ;
Sidner, RA ;
Bearden, CM ;
Gebel, HM ;
Roggero, AL ;
Fineberg, NS ;
Taber, T ;
Kraus, MA ;
Pescovitz, MD .
TRANSPLANTATION, 2004, 77 (04) :542-548